NOT-AR-23-019: Notice of NIAMS Withdrawal from PA-20-195 "Parent R21 Exploratory/Developmental Grant, Clinical Trial Not Allowed"

Notice of NIAMS Withdrawal from PA-20-195 "Parent R21 Exploratory/Developmental Grant, Clinical Trial Not Allowed"

Notice Number:

NOT-AR-23-019

Key Dates

Release Date:

April 20,2023

Related Announcements

PA-20-195 - Parent R21 Exploratory/Developmental Grant, Clinical Trial Not Allowed

Issued by

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Purpose

The purpose of this Notice is to inform prospective applicants that effective May 8, 2023, the NIAMS will withdraw from the Parent R21 Exploratory/Developmental Grant, Clinical Trial Not Allowed Notice of Funding Opportunity (NOFO) PA-20-195. NIAMS will only accept R21 applications in response to a Notice of Special Interest (NOSI).

Inquiries

Please direct all inquiries to:

Alexey Belkin, Ph.D.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301-827-6475
Email: alexey.belkin@nih.gov